Stanford Autonomic Disorders Program Clinical Trials
Autonomic Complications of Post-Acute COVID Syndrome
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Barbara Hung or Adele Viviani
Contact: autonomicresearch@stanford.edu
North American Prodromal Synucleinopathy Stage 2 (NAPS2) Consortium
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Adele Viviani
Contact: autonomicresearch@stanford.edu
Autonomic Complications of PASC (RECOVER)
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Adele Viviani
Contact: autonomicresearch@stanford.edu
Open-label prospective study for immune therapies in autoimmune gastrointestinal dysmotility (AGID)
PI: Dong-In Sinn, MD
Study Status: Open to enrollment
Research Coordinator: Barbara Hung
Contact: autonomicresearch@stanford.edu
A Phase 3, Multi-center, Randomized Withdrawal and Long-Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants with Multiple System Atrophy
PI: Dong-In Sinn, MD
Study Status: Open to enrollment
Research Coordinator: Jordan Seliger or Adele Viviani
Contact: autonomicresearch@stanford.edu
Syn-Sleep Study
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Adele Viviani
Contact: autonomicresearch@stanford.edu
A Phase 2, double-blind, placebo-controlled, parallel-group study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and potential efficacy of multiple doses of ONO-2808 in patients with Multiple System Atrophy (MSA)
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Jordan Seliger or Barbara Hung
Contact: autonomicresearch@stanford.edu